Frontlight ResearchEarly access
CompletedNo phase
Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study
Key facts
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Where
- Cincinnati, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 31 people enrolled
- Started
- 10 Nov 2023
- Ended
- 1 Nov 2025
- Type of study
- Interventional
- Treatments tested
- Personalized ADHD Medication Experiment
- Record updated
- 5 May 2026
Who can take part
- Age
- 11 years to 15 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Consent: A parent or legal guardian must provide written informed consent
- Assent: Adolescents must provide written assent to participate in the study
- Ages 11-15
- Treated for ADHD by pediatrician
- First prescribed ADHD medicine more than one year prior to enrollment
- Filled at least one prescription for a stimulant medication in the past year
- Uncertainty about continued ADHD medication use
- Only one child per household can participate in the study. For families who have more than one child who is potentially eligible, they may decide which of their children would be the best fit for the study
Who cannot take part
- Do not have reliable access to the internet at their home or another location
- Will not permit their child to access the internet for study related activities
- Are not able or willing to send or receive text messages
Where in United States
- Cincinnati Children's Hospital Medical CenterCincinnati, United States
About the trial
What the trial wants to find out
The primary goal of the project is to test personalized medication experiments to inform decisions about future medication use. Our central hypothesis is that our intervention will lead to within subject increases in adolescent involvement in decision making and decreases in uncertainty about future medication use. The investigators view this open label trial as a pilot study to test the feasibility, acceptability, and preliminary efficacy of the medication experiment intervention and therefore warrants further testing in a future larger trial.
The group in the trial
- InterventionTreatment being tested
All will choose one of five medication experiment options to complete.
Treatment: Personalized ADHD Medication Experiment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Open-Label Trial of Personalized Medication Experiments to Inform Decisions About Future Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Use
- Record updated
- 5 May 2026